LAB
Standard Biotools Inc
NASDAQ: LAB · HEALTHCARE · MEDICAL DEVICES
$0.93
+4.69% today
Updated 2026-04-30
Market cap
$350.48M
P/E ratio
—
P/S ratio
4.11x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
2.7M
Standard Biotools Inc (LAB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.40M | $7.28M | $15.35M | $25.41M | $33.56M | $42.87M | $52.33M | $71.18M | $116.46M | $114.71M | $104.45M | $101.94M | $112.96M | $117.24M | $138.14M | $130.58M | $97.95M | $106.34M | $174.43M | $85.33M |
| Revenue growth (YoY) | — | +13.7% | +111.0% | +65.6% | +32.1% | +27.7% | +22.1% | +36.0% | +63.6% | -1.5% | -8.9% | -2.4% | +10.8% | +3.8% | +17.8% | -5.5% | -25.0% | +8.6% | +64.0% | -51.1% |
| Cost of revenue | $2.77M | $3.51M | $8.36M | $11.49M | $11.58M | $13.19M | $15.32M | $20.08M | $42.85M | $46.63M | $46.01M | $49.95M | $51.31M | $52.96M | $54.82M | $53.31M | $60.90M | $55.89M | $90.17M | $42.79M |
| Gross profit | $3.63M | $3.76M | $6.98M | $13.93M | $21.98M | $29.67M | $37.01M | $51.10M | $73.61M | $68.08M | $58.44M | $51.98M | $61.65M | $64.28M | $83.33M | $77.27M | $37.05M | $50.45M | $84.26M | $42.54M |
| Gross margin | 56.7% | 51.7% | 45.5% | 54.8% | 65.5% | 69.2% | 70.7% | 71.8% | 63.2% | 59.4% | 55.9% | 51.0% | 54.6% | 54.8% | 60.3% | 59.2% | 37.8% | 47.4% | 48.3% | 49.9% |
| R&D | $15.59M | $14.39M | $14.02M | $12.31M | $13.01M | $13.94M | $16.60M | $19.73M | $43.42M | $39.26M | $38.41M | $30.83M | $30.03M | $31.64M | $36.46M | $37.94M | $37.38M | $25.95M | $62.41M | $25.99M |
| SG&A | — | — | — | — | — | — | — | — | — | — | $93.21M | $79.52M | $79.78M | $84.48M | $97.90M | $98.89M | $114.76M | $98.88M | $156.61M | $109.86M |
| Operating income | $-21.66M | $-23.53M | $-29.54M | $-18.04M | $-14.57M | $-18.57M | $-18.07M | $-17.95M | $-51.84M | $-50.16M | $-73.19M | $-58.36M | $-48.16M | $-51.84M | $-51.04M | $-67.46M | $-116.20M | $-76.60M | $-175.24M | $-93.31M |
| Operating margin | -338.6% | -323.4% | -192.5% | -71.0% | -43.4% | -43.3% | -34.5% | -25.2% | -44.5% | -43.7% | -70.1% | -57.3% | -42.6% | -44.2% | -36.9% | -51.7% | -118.6% | -72.0% | -100.5% | -109.3% |
| EBITDA | $-19.83M | $-20.91M | $-26.12M | $-14.67M | $-13.52M | $-18.14M | $-16.78M | $-13.82M | $-38.50M | $-32.87M | $-56.42M | $-39.67M | $-31.03M | $-46.62M | $-34.60M | $-44.26M | $-173.57M | $-54.46M | $-118.14M | $-94.96M |
| EBITDA margin | -310.0% | -287.5% | -170.2% | -57.7% | -40.3% | -42.3% | -32.1% | -19.4% | -33.1% | -28.7% | -54.0% | -38.9% | -27.5% | -39.8% | -25.0% | -33.9% | -177.2% | -51.2% | -67.7% | -111.3% |
| EBIT | $-21.29M | $-23.05M | $-28.09M | $-16.61M | $-15.03M | $-19.20M | $-18.26M | $-16.38M | $-42.56M | $-48.98M | $-74.36M | $-57.98M | $-47.53M | $-62.43M | $-50.53M | $-67.46M | $-188.60M | $-69.64M | $-135.00M | $-96.68M |
| Interest expense | $2.26M | $2.79M | $2.03M | $2.88M | $2.16M | $3.10M | $628000.00 | $14000.00 | $5.34M | $5.81M | $5.82M | $5.82M | $13.89M | $4.28M | $3.57M | $3.82M | $4.33M | $4.57M | $3.32M | $26000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-23.55M | $-25.45M | $-29.50M | $-19.13M | $-16.90M | $-22.47M | $-19.02M | $-15.82M | $-52.83M | $-53.31M | $-75.98M | $-60.53M | $-59.01M | $-64.79M | $-53.02M | $-59.24M | $-190.10M | $-74.66M | $-138.88M | $-74.90M |
| Net income growth (YoY) | — | -8.1% | -15.9% | +35.2% | +11.6% | -32.9% | +15.3% | +16.8% | -233.9% | -0.9% | -42.5% | +20.3% | +2.5% | -9.8% | +18.2% | -11.7% | -220.9% | +60.7% | -86.0% | +46.1% |
| Profit margin | -368.1% | -349.8% | -192.2% | -75.3% | -50.4% | -52.4% | -36.4% | -22.2% | -45.4% | -46.5% | -72.8% | -59.4% | -52.2% | -55.3% | -38.4% | -45.4% | -194.1% | -70.2% | -79.6% | -87.8% |